These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18363539)

  • 1. Gynecomastia possibly induced by rosuvastatin.
    Oteri A; Catania MA; Travaglini R; Russo A; Giustini SE; Caputi AP; Polimeni G
    Pharmacotherapy; 2008 Apr; 28(4):549-51. PubMed ID: 18363539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?
    Singh S; Nautiyal A; Dolan JG
    JOP; 2004 Nov; 5(6):502-4. PubMed ID: 15536291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term memory loss associated with rosuvastatin.
    Galatti L; Polimeni G; Salvo F; Romani M; Sessa A; Spina E
    Pharmacotherapy; 2006 Aug; 26(8):1190-2. PubMed ID: 16863497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golf-inhibiting gynecomastia associated with atorvastatin therapy.
    Hammons KB; Edwards RF; Rice WY
    Pharmacotherapy; 2006 Aug; 26(8):1165-8. PubMed ID: 16863492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin-induced gynaecomastia.
    Picolos MK; Zeniou V; Michalis A
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):421-2. PubMed ID: 20346003
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J; Sullivan D; Smith M
    Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of rosuvastatin.
    Shepherd J; Hunninghake DB; Stein EA; Kastelein JJ; Harris S; Pears J; Hutchinson HG
    Am J Cardiol; 2004 Oct; 94(7):882-8. PubMed ID: 15464670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.
    Shepherd J; Vidt DG; Miller E; Harris S; Blasetto J
    Cardiology; 2007; 107(4):433-43. PubMed ID: 17363845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-selective gynecomastia.
    Kaufman KR; Podolsky D; Greenman D; Madraswala R
    Ann Pharmacother; 2013 Jan; 47(1):e6. PubMed ID: 23324513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
    Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
    Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.
    Martikainen JE; Saastamoinen LK; Korhonen MJ; Enlund H; Helin-Salmivaara A
    Med Care; 2010 Sep; 48(9):761-6. PubMed ID: 20706164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.
    McAfee AT; Ming EE; Seeger JD; Quinn SG; Ng EW; Danielson JD; Cutone JA; Fox JC; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):444-53. PubMed ID: 16761308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
    Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG; Heintjes EM; Kastelein JJ; Rabelink TJ; Johansson S; Herings RM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure with the combined use of rosuvastatin and fenofibrate.
    Buyukhatipoglu H; Sezen Y; Guntekin U; Kirhan I; Dag OF
    Ren Fail; 2010 Jun; 32(5):633-5. PubMed ID: 20486848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin, the black box.
    Hatem S; Boccara F
    Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.